Skip to content
  • Tuesday, 27 October 2026
  • 11:07 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ontario Bioscience Innovation Organization Capital Access Advisory Program Crosses C$1bn Milestone and Unveils 2026 Cohort
Pharmaceutical R&D

Ontario Bioscience Innovation Organization Capital Access Advisory Program Crosses C$1bn Milestone and Unveils 2026 Cohort

Teuku Ryan Sep 30, 2026 0

The landscape of Canadian health sciences received a monumental boost as the Ontario Bioscience Innovation Organization (OBIO) announced that enterprises…

Read More
Pharmaceutical R&D

Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital, and industry converge at Campus Grand Parc.

Teuku Ryan Jul 4, 2026 0

The recent inauguration of THE HIVE at Campus Grand Parc in Paris marks a significant inflection point for Europe’s oncology…

Read More
Data Science & Bioinformatics

The 7 Best Ways to Fund Your Startup Idea: A Comprehensive Guide to Navigating the Capital Landscape

Evan Lee Salim Jun 15, 2026 0

The journey of transforming an innovative idea into a thriving enterprise often hinges on securing adequate capital. While venture capital…

Read More
Pharmaceutical R&D

CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership

Teuku Ryan May 23, 2026 0

One of Italy’s few remaining publicly traded large pharmaceutical companies, Recordati, is on the cusp of transitioning to private ownership…

Read More
Pharmaceutical R&D

Global Healthcare Giants Unite: GHO Capital and CBC Group Forge Largest Dedicated Investment Manager with $21 Billion AUM

Teuku Ryan May 20, 2026 0

Two prominent forces in specialized healthcare investment, Global Healthcare Opportunities (GHO) and CBC Group, have announced a groundbreaking merger to…

Read More
Pharmaceutical R&D

AI Tools Revolutionize Pharmaceutical Administration, Freeing Up Valuable Human Capital

Teuku Ryan Apr 27, 2026 0

The pharmaceutical industry is experiencing a significant transformation as artificial intelligence (AI) tools move beyond experimental phases to deliver tangible…

Read More
Pharmaceutical R&D

Jeito Capital’s Second Fund Closes Above Target, Bolstering European Biopharma Investment to Over €1.6 Billion

Teuku Ryan Apr 10, 2026 0

Global independent private equity fund Jeito Capital has achieved a significant milestone in European biopharma investment with the successful closure…

Read More
Decoding the Ambiguity of AI Experience in Modern Data Science RecruitmentCaltech Researchers Unlock Sub-Picosecond Optical Switching with Breakthrough Metasurface TechnologyNICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UKTWiV 1290: Clinical update with Dr. Daniel Griffin | Microbe TV
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ